iCamumo
Suzhou
About iCamumo
Aikai Biotech is focused on developing a new generation of off-the-shelf general-purpose cell therapy pharmaceuticals using iPSC.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $75.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2026)
- Website: icamunobio.com
- Phone: +86-021-68060188
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/icamumo-106858 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.